Mingjuan Lisa Zhang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytodiagnosis | 6 | 2023 | 447 | 2.120 |
Why?
|
Pancreatic Cyst | 3 | 2024 | 367 | 1.850 |
Why?
|
Urothelium | 5 | 2020 | 269 | 1.820 |
Why?
|
Urologic Neoplasms | 5 | 2020 | 313 | 1.580 |
Why?
|
Urine | 5 | 2020 | 362 | 1.490 |
Why?
|
Pancreatic Neoplasms | 6 | 2024 | 5363 | 1.210 |
Why?
|
Carcinoma | 6 | 2022 | 2328 | 1.150 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2020 | 2210 | 0.820 |
Why?
|
Jaundice | 1 | 2022 | 96 | 0.780 |
Why?
|
Colitis, Ischemic | 1 | 2021 | 32 | 0.760 |
Why?
|
Digestive System | 1 | 2022 | 244 | 0.740 |
Why?
|
Enterocolitis | 1 | 2021 | 106 | 0.700 |
Why?
|
Digestive System Diseases | 1 | 2022 | 151 | 0.700 |
Why?
|
Body Fluids | 1 | 2021 | 319 | 0.650 |
Why?
|
Cell Nucleus | 3 | 2017 | 2909 | 0.640 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 117 | 0.590 |
Why?
|
Cystadenoma, Serous | 1 | 2018 | 100 | 0.580 |
Why?
|
Mediastinal Neoplasms | 1 | 2020 | 402 | 0.570 |
Why?
|
Laboratories | 1 | 2021 | 462 | 0.560 |
Why?
|
Osteosarcoma | 1 | 2023 | 896 | 0.560 |
Why?
|
Urinary Tract | 1 | 2020 | 313 | 0.550 |
Why?
|
Adenocarcinoma | 4 | 2023 | 6332 | 0.550 |
Why?
|
Surgical Instruments | 1 | 2018 | 382 | 0.500 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2017 | 168 | 0.500 |
Why?
|
Hypoglycemia | 1 | 2022 | 884 | 0.490 |
Why?
|
Glaucoma | 2 | 2015 | 1185 | 0.490 |
Why?
|
Eye Neoplasms | 1 | 2017 | 307 | 0.480 |
Why?
|
Cytoplasm | 2 | 2017 | 1511 | 0.480 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2022 | 1089 | 0.480 |
Why?
|
Hematuria | 1 | 2016 | 233 | 0.480 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 953 | 0.460 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1156 | 0.450 |
Why?
|
Cyst Fluid | 2 | 2024 | 83 | 0.440 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2017 | 781 | 0.440 |
Why?
|
Phacoemulsification | 1 | 2015 | 149 | 0.440 |
Why?
|
Trabeculectomy | 1 | 2015 | 174 | 0.440 |
Why?
|
Intraocular Pressure | 2 | 2015 | 1293 | 0.390 |
Why?
|
Sarcoma | 1 | 2023 | 1793 | 0.390 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1198 | 0.370 |
Why?
|
Lymphoma | 1 | 2020 | 1901 | 0.370 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2527 | 0.360 |
Why?
|
Biopsy | 5 | 2023 | 6768 | 0.330 |
Why?
|
Flow Cytometry | 1 | 2020 | 5866 | 0.330 |
Why?
|
Cataract | 1 | 2015 | 832 | 0.320 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1726 | 0.320 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1896 | 0.300 |
Why?
|
Colonic Neoplasms | 3 | 2022 | 2534 | 0.260 |
Why?
|
Therapeutic Irrigation | 2 | 2017 | 292 | 0.260 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3200 | 0.260 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11098 | 0.250 |
Why?
|
Triage | 2 | 2023 | 986 | 0.240 |
Why?
|
Humans | 38 | 2024 | 761326 | 0.220 |
Why?
|
Carcinoembryonic Antigen | 1 | 2024 | 337 | 0.210 |
Why?
|
Aged | 15 | 2024 | 169179 | 0.210 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9180 | 0.210 |
Why?
|
Middle Aged | 15 | 2024 | 220774 | 0.190 |
Why?
|
Cytological Techniques | 1 | 2023 | 218 | 0.190 |
Why?
|
Male | 18 | 2024 | 360621 | 0.180 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 12972 | 0.180 |
Why?
|
Erythroblasts | 1 | 2021 | 142 | 0.180 |
Why?
|
Clinical Competence | 1 | 2016 | 4793 | 0.180 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58946 | 0.170 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.170 |
Why?
|
Inflammation | 1 | 2019 | 10760 | 0.170 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.170 |
Why?
|
Erythroid Cells | 1 | 2021 | 238 | 0.170 |
Why?
|
Nuclear Envelope | 1 | 2020 | 163 | 0.160 |
Why?
|
Facial Neoplasms | 1 | 2020 | 125 | 0.160 |
Why?
|
Female | 17 | 2024 | 392485 | 0.160 |
Why?
|
Barrett Esophagus | 1 | 2023 | 490 | 0.160 |
Why?
|
Urinalysis | 1 | 2020 | 368 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 517 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.150 |
Why?
|
Orbital Neoplasms | 1 | 2020 | 223 | 0.150 |
Why?
|
Gastritis | 1 | 2019 | 199 | 0.150 |
Why?
|
Lymphocyte Count | 1 | 2020 | 778 | 0.150 |
Why?
|
Colonic Polyps | 1 | 2022 | 554 | 0.140 |
Why?
|
Hematology | 1 | 2021 | 244 | 0.140 |
Why?
|
Pathology | 1 | 2020 | 270 | 0.140 |
Why?
|
Adult | 11 | 2024 | 221122 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 260 | 0.140 |
Why?
|
Specimen Handling | 1 | 2021 | 703 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1742 | 0.130 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 15262 | 0.130 |
Why?
|
Pancreas | 1 | 2022 | 1689 | 0.130 |
Why?
|
Diarrhea | 1 | 2022 | 1319 | 0.130 |
Why?
|
Stomach | 1 | 2019 | 694 | 0.120 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3873 | 0.120 |
Why?
|
Microscopy | 1 | 2020 | 902 | 0.120 |
Why?
|
BK Virus | 1 | 2016 | 123 | 0.120 |
Why?
|
Neurofibromatosis 1 | 1 | 2020 | 560 | 0.120 |
Why?
|
Trabecular Meshwork | 1 | 2015 | 101 | 0.120 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2509 | 0.120 |
Why?
|
Lymphocytes | 1 | 2022 | 2610 | 0.110 |
Why?
|
Polyomavirus Infections | 1 | 2016 | 194 | 0.110 |
Why?
|
Observer Variation | 2 | 2018 | 2605 | 0.110 |
Why?
|
Europe | 1 | 2020 | 3420 | 0.110 |
Why?
|
Tumor Virus Infections | 1 | 2016 | 438 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1647 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6901 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3512 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2159 | 0.100 |
Why?
|
Colon | 1 | 2019 | 1792 | 0.100 |
Why?
|
Antigens, CD | 1 | 2021 | 4000 | 0.090 |
Why?
|
Colitis | 1 | 2019 | 1231 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 1394 | 0.090 |
Why?
|
Bone Marrow | 1 | 2021 | 2909 | 0.090 |
Why?
|
Forkhead Transcription Factors | 3 | 2022 | 1612 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2413 | 0.090 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39108 | 0.080 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2823 | 0.080 |
Why?
|
Chromatin | 1 | 2020 | 2960 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2022 | 2052 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6815 | 0.080 |
Why?
|
Cohort Studies | 4 | 2020 | 41440 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4022 | 0.070 |
Why?
|
Young Adult | 3 | 2024 | 59196 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2024 | 80575 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3356 | 0.060 |
Why?
|
Quality Improvement | 1 | 2021 | 3800 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14665 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13251 | 0.060 |
Why?
|
Prognosis | 3 | 2022 | 29588 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3666 | 0.060 |
Why?
|
Stents | 1 | 2015 | 3179 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8526 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11070 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5303 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5670 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20092 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 197 | 0.050 |
Why?
|
Coloring Agents | 1 | 2023 | 559 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8635 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14025 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 428 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 568 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10203 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 22124 | 0.040 |
Why?
|
Biopsy, Fine-Needle | 1 | 2022 | 1118 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13333 | 0.040 |
Why?
|
Computer-Assisted Instruction | 1 | 2020 | 362 | 0.030 |
Why?
|
Faculty | 1 | 2020 | 383 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3271 | 0.030 |
Why?
|
Photography | 1 | 2017 | 532 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 64645 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4810 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2023 | 2911 | 0.030 |
Why?
|
Prospective Studies | 1 | 2014 | 54405 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36430 | 0.020 |
Why?
|
Child | 1 | 2017 | 80156 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 88305 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4576 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4383 | 0.020 |
Why?
|
Transcription Factors | 1 | 2020 | 12122 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8997 | 0.010 |
Why?
|
United States | 1 | 2023 | 72317 | 0.010 |
Why?
|